Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid- In Capital	Accumulated Other Comprehensive (Loss) Income	Retained Deficit
Beginning balance at Sep. 30, 2022	$ 98,368	$ 140	$ 124,458	$ (1,767)	$ (24,463)
Beginning balance (in shares) at Sep. 30, 2022		13,994,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(2,744)				(2,744)
Translation adjustment	416			416
Stock compensation expense	164		164
Stock options exercised	34		34
Stock options exercised (in shares)		9,000
Ending balance at Dec. 31, 2022	96,238	$ 140	124,656	(1,351)	(27,207)
Ending balance (in shares) at Dec. 31, 2022		14,003,000
Beginning balance at Sep. 30, 2022	98,368	$ 140	124,458	(1,767)	(24,463)
Beginning balance (in shares) at Sep. 30, 2022		13,994,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	460
Ending balance at Mar. 31, 2023	100,297	$ 140	125,127	(967)	(24,003)
Ending balance (in shares) at Mar. 31, 2023		14,039,000
Beginning balance at Dec. 31, 2022	96,238	$ 140	124,656	(1,351)	(27,207)
Beginning balance (in shares) at Dec. 31, 2022		14,003,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	3,204				3,204
Translation adjustment	384			384
Stock compensation expense	174		174
Stock options exercised	297		297
Stock options exercised (in shares)		36,000
Ending balance at Mar. 31, 2023	100,297	$ 140	125,127	(967)	(24,003)
Ending balance (in shares) at Mar. 31, 2023		14,039,000
Beginning balance at Sep. 30, 2023	$ 88,365	$ 142	126,963	(1,695)	(37,045)
Beginning balance (in shares) at Sep. 30, 2023	14,185,977	14,186,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ (9,358)				(9,358)
Translation adjustment	269			269
Stock compensation expense	317		317
Stock options exercised	28		28
Stock options exercised (in shares)		5,000
Ending balance at Dec. 31, 2023	79,621	$ 142	127,308	(1,426)	(46,403)
Ending balance (in shares) at Dec. 31, 2023		14,191,000
Beginning balance at Sep. 30, 2023	$ 88,365	$ 142	126,963	(1,695)	(37,045)
Beginning balance (in shares) at Sep. 30, 2023	14,185,977	14,186,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ (8,388)
Ending balance at Mar. 31, 2024	$ 80,891	$ 142	127,658	(1,476)	(45,433)
Ending balance (in shares) at Mar. 31, 2024	14,208,795	14,209,000
Beginning balance at Dec. 31, 2023	$ 79,621	$ 142	127,308	(1,426)	(46,403)
Beginning balance (in shares) at Dec. 31, 2023		14,191,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	970				970
Translation adjustment	(50)			(50)
Stock compensation expense	350		350
Stock options exercised (in shares)		18,000
Ending balance at Mar. 31, 2024	$ 80,891	$ 142	$ 127,658	$ (1,476)	$ (45,433)
Ending balance (in shares) at Mar. 31, 2024	14,208,795	14,209,000